SciMed Biotech Podcast with Benjamin Fyrer of Pluristyx

Pushing the Boundaries of Healing with Benjamin Fryer's Stem Cell Breakthroughs

In this episode of the SciMed Biotech Podcast, we sit down with Dr. Benjamin Fryer, co-founder and CEO of Pluristyx, to explore his trailblazing work in stem cell research. Dr. Fryer, with a rich background that spans academia, start-ups, and big pharma, has been at the forefront of developing therapies that could one day revolutionize how we treat diseases. At Pluristyx, he's helping to push the boundaries of medicine by making it easier for other companies to develop and commercialize new treatments. Join us as Dr. Fryer shares insights from his journey in science and leadership, and explains how his team's work is opening up new possibilities for health and healing. This conversation is perfect for anyone curious about the future of healthcare and the innovative technologies that will drive it.